Research Options:
Week of Expected Pricing Pending
Company Name Cutanea life sciences Inc.
Proposed Ticker CTNA
CUSIP 23210P102
Business Description A development stage specialty pharmaceutical company that in-licenses and develops novel therapeutics for the treatment of dermatological conditions.
Lead Underwriter Brean Murray, Carret & Co., LLC , Rodman & Renshaw, LLC
Co-Managers N/A
Initial Shares 2300000
Revised Initial Shares N/A
Initial Price $6.00-$7.00
Revised Price N/A
Final Price N/A
Final Ticker N/A

 

 
   
  © 2024 ICE Data Services. All rights reserved.